Physiomics Plc

PYC.L·LSE·Healthcare
Compare
0.5000+0.0250 (+5.26%)today
As of Oct 21, 8:31 AM BST · May be delayed up to 15 min · GBX

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.4750
Open0.5000
Day range—
52-week range0.25300.8000
Off day high0.00%
Off 52-week high−37.50%
Volume34.00
Avg. volume (3M)3.08M
Market cap2.27M
EPS (TTM)0.000000
Forward P/E-0.01
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.03
Shares outstanding453.21M
Short interest—
Earnings dateMar 6, 2025
Analyst target—
Profit margin−66.06%

Latest news

All PYC.L news ›
Share Talk·Positive

Physiomics secures drug development contract

Physiomics plc (AIM: PYC) has secured a new £119,000 contract for drug development modelling while exploring additional commercial opportunities for its personalised dosing technology, including potential expansion into the US and wellness…

From articles in the 4Search news index.

In the news

5mentions in 30 days
5with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.